Articles by Anthony J. DeStefano, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Anthony J. DeStefano, PhD

Changing the Dynamic of CROs

External partnering expands an organizations capabilities and challenges.
Oct 2, 2013

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Inside USP: US Pharmacopeia Proposes New Standard on Glass Quality

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Jun 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: A Holistic Approach to Supply-Chain Integrity

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Mar 2, 2012

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.

Inside USP: Global Harmonization Presents Opportunities and Challenges

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.
Jan 2, 2012

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.

Inside USP: Adulteration and Contamination Awareness

USP is working to ensure quality standards and to increase public information.
Nov 2, 2010

USP is working to ensure quality standards and to increase public information.

Inside USP: USP Metals Testing: A Workshop Report

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.
Nov 2, 2008

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here